Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aquilon Pharmaceuticals

Aquilon Pharmaceuticals?uq=UG6efJS6
PRIVATE STATUS
Series A LATEST DEAL TYPE
$387K LATEST DEAL AMOUNT
2 INVESTORS
Description

Operator of a pharmaceutical company developing drugs for the treatment of pulmonary diseases. The company focuses on the development of drugs for the treatment of respiratory disorders.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 76 Rue Porte de Lorette
  • 4600 Vise
  • Belgium
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aquilon Pharmaceuticals’s full profile, request a free trial.

Aquilon Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 26-Oct-2015 $387K 00000 00000 Completed Startup
1. Accelerator/Incubator 14-Nov-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Aquilon Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Be Angels Angel Group Minority 000 0000 000000 0
WBC Accelerator/Incubator 000 0000 000000 0

Aquilon Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Paul Maes Chief Executive Officer & Chairman
Didier Cataldo Co-Founder & Administrator
Brigitte Evrard Co-Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Aquilon Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
Paul Maes Aquilon Pharmaceuticals Chief Executive Officer & Chairman 000 0000